| Gufic BioSciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 509079 |
NSE Symbol : GUFICBIO |
P/E(TTM) : 56.79 |
|
ISIN Demat : INE742B01025 |
Div & Yield% : 0.02 |
EPS(TTM) : 7.33 |
|
Book Value(₹) : 66.23 |
Market Cap(₹Cr) : 4,174.26 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 260.82 | 252.05 | 231.09 | 230.42 | 226.91 | 205.02 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 260.82 | 252.05 | 231.09 | 230.42 | 226.91 | 205.02 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.46 | -1.20 | 0.79 | 2.09 | 0.89 | 0.38 |
| Total Income | 261.28 | 250.86 | 231.89 | 232.51 | 227.81 | 205.40 |
| Total Expenditure | 214.09 | 206.14 | 194.79 | 194.62 | 194.58 | 178.38 |
| PBIDT | 47.19 | 44.71 | 37.10 | 37.89 | 33.23 | 27.02 |
| Interest | 9.32 | 9.44 | 8.36 | 9.58 | 9.23 | 8.40 |
| PBDT | 37.87 | 35.28 | 28.74 | 28.30 | 24.00 | 18.62 |
| Depreciation | 7.71 | 7.65 | 7.69 | 7.77 | 7.72 | 7.84 |
| Tax | 6.08 | 4.63 | 3.30 | 3.55 | 2.22 | 0.29 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.62 | 2.42 | 2.19 | 2.04 | 1.98 | 2.51 |
| Reported Profit After Tax | 22.46 | 20.57 | 15.56 | 14.94 | 12.07 | 7.97 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 22.46 | 20.57 | 15.56 | 14.94 | 12.07 | 7.97 |
| EPS (Unit Curr.) | 2.24 | 2.05 | 1.55 | 1.49 | 1.20 | 0.80 |
| EPS (Adj) (Unit Curr.) | 2.24 | 2.05 | 1.55 | 1.49 | 1.20 | 0.80 |
| Calculated EPS (Unit Curr.) | 2.24 | 2.05 | 1.55 | 1.49 | 1.20 | 0.80 |
| Calculated EPS (Adj) (Unit Curr.) | 2.24 | 2.05 | 1.55 | 1.49 | 1.20 | 0.80 |
| Calculated EPS (Ann.) (Unit Curr.) | 8.96 | 8.21 | 6.21 | 5.96 | 4.82 | 3.18 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 8.96 | 8.21 | 6.21 | 5.96 | 4.82 | 3.18 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.03 | 10.03 | 10.03 | 10.03 | 10.03 | 10.03 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 18.09 | 17.74 | 16.05 | 16.44 | 14.64 | 13.18 |
| PBDTM(%) | 14.52 | 14.00 | 12.44 | 12.28 | 10.58 | 9.08 |
| PATM(%) | 8.61 | 8.16 | 6.73 | 6.48 | 5.32 | 3.89 |
